Clinical outcomes and safety of polymyxin B versus tigecycline combination therapy for pneumonia of carbapenem-resistant <i>Klebsiella pneumoniae</i> : a retrospective cohort study
Polymyxin B-based combination therapy at the standard dose should be used with caution for patients with CRKP-induced pneumonia, especially for men who used carbapenems prior to CRKP detection.
Authors
- Wenfang Sun (ORCID: https://orcid.org/0000-0001-7287-6923)
- Binbin Xia (ORCID: https://orcid.org/0000-0002-0065-072X)
- Jing Chen (ORCID: https://orcid.org/0000-0002-2681-0349)
- Fang Liu (ORCID: https://orcid.org/0000-0003-0363-5389)
- Hua Cheng (ORCID: https://orcid.org/0000-0003-0310-3526)
- Yang Liu (ORCID: https://orcid.org/0000-0001-5939-572X)
- Jingyao Pang
Institutions
- Beijing Luhe Hospital Affiliated to Capital Medical University (CN)
Publication Details
- Journal
- Annals of Medicine
- Published
- 2024-09-06
- DOI
- https://doi.org/10.1080/07853890.2024.2397087
- Citations
- 1
- Primary Topic
- Antibiotic Resistance in Bacteria
- Type
- article
- Field-Weighted Citation Impact
- 0.17